Corcept Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.

About CORT

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.

CEO

Joseph K. Belanoff

CEOJoseph K. Belanoff

Employees

500

Employees500

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

1998

Founded1998

Employees

500

Employees500

CORT Key Statistics

Market cap

9.31B

Market cap9.31B

Price-Earnings ratio

78.70

Price-Earnings ratio78.70

Dividend yield

—

Dividend yield—

Average volume

744.93K

Average volume744.93K

High today

$90.26

High today$90.26

Low today

$88.07

Low today$88.07

Open price

$88.57

Open price$88.57

Volume

690.04K

Volume690.04K

52 Week high

$117.33

52 Week high$117.33

52 Week low

$42.01

52 Week low$42.01

CORT News

Simply Wall St 3d

Corcept Therapeutics Incorporated Stocks Shoot Up 30% But Its P/E Still Looks Reasonable

The Corcept Therapeutics Incorporated ( ) share price has done very well over the last month, posting an excellent gain of 30%. The annual gain comes to 101% fo...

TipRanks 3d

Corcept Therapeutics Board Member Resigns, Continues as Consultant

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Simply Wall St 5d

A Fresh Look at Corcept Therapeutics Valuation Following New Care Partnerships and Pipeline Expansion

Corcept Therapeutics (CORT) recently partnered with Curant Health’s Curant Rare division to support patients with personalized care and improved access to thera...

More CORT News

Simply Wall St 7d

How Could Corcept Specialty Pharmacy Partnership Reflect Its Approach to Diversifying Beyond Korlym?

Curant Health recently announced that its Curant Rare division was selected by Corcept Therapeutics to provide specialty pharmacy services, focusing on enhancin...

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.

Broadcom

Robinhood Markets

Novo Nordisk

Palantir Technologies

Gilead Sciences

Spotify